Table 9: Primary (Malignant and Non-Malignant) Brain
and Central Nervous System Tumor Incidence Ratesa by Major Histology Groupings,
Histology and Gender, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS
1995-1999b
|
|
Males |
Females |
||
Histology
|
N |
Adjusted
Rate |
N |
Adjusted
Rate |
|
|
|
|
|
|
Tumors of Neuroepithelial Tissue
|
10,061 |
8.02 |
8,103 |
5.62 |
|
Pilocytic
astrocytoma |
410 |
0.30 |
375 |
0.28 |
|
Diffuse
astrocytoma (protoplasmic, fibrillary) |
213 |
0.17 |
146 |
0.10 |
|
Anaplastic
astrocytoma |
757 |
0.60 |
631 |
0.44 |
|
Unique
astrocytoma variants |
97 |
0.08 |
74 |
0.05 |
|
Astrocytoma,
NOS |
908 |
0.71 |
675 |
0.47 |
|
Glioblastoma |
4,851 |
4.02 |
3,837 |
2.59 |
|
Oligodendroglioma |
586 |
0.44 |
497 |
0.35 |
|
Anaplastic
oligodendroglioma |
229 |
0.17 |
199 |
0.14 |
|
Ependymoma/anaplastic
ependymoma |
380 |
0.29 |
294 |
0.21 |
|
Ependymoma
variants |
92 |
0.07 |
58 |
0.04 |
|
Mixed
glioma |
215 |
0.16 |
177 |
0.13 |
|
Glioma
malignant, NOS |
536 |
0.43 |
499 |
0.34 |
|
Choroid
plexus |
43 |
0.03 |
49 |
0.04 |
|
Neuroepithelial |
20 |
0.02 |
21 |
0.01 |
|
Benign
and malignant neuronal/glial, neuronal and mixed |
269 |
0.20 |
230 |
0.17 |
|
Pineal
parenchymal |
34 |
0.03 |
43 |
0.03 |
|
Embryonal/primitive/medulloblastoma |
421 |
0.31 |
298 |
0.22 |
|
|
|
|
|
|
Tumors of Cranial and Spinal Nerves
|
1,351 |
1.07 |
1,471 |
1.04 |
|
Nerve
sheath, benign and malignant |
1,351 |
1.07 |
1,471 |
1.04 |
|
Other
tumors of cranial and spinal nerves |
- |
- |
- |
- |
|
|
|
|
|
|
Tumors of the Meninges
|
3,149 |
2.66 |
7,680 |
5.19 |
|
Meningioma |
2,891 |
2.46 |
7,466 |
5.04 |
|
Other
mesenchymal, benign and malignant |
70 |
0.06 |
61 |
0.04 |
|
Hemangioblastoma |
188 |
0.15 |
153 |
0.11 |
|
|
|
|
|
|
Lymphomas and Hemopoietic Neoplasms
|
597 |
0.47 |
409 |
0.28 |
|
Lymphoma |
597 |
0.47 |
409 |
0.28 |
|
|
|
|
|
|
Germ Cell Tumors and Cysts
|
149 |
0.11 |
53 |
0.04 |
|
Germ
cell tumors, cysts and heterotopias |
149 |
0.11 |
53 |
0.04 |
|
|
|
|
|
|
Tumors of the Sellar Region
|
1,393 |
1.11 |
1,412 |
1.00 |
|
Pituitary |
1,242 |
1.00 |
1,254 |
0.88 |
|
Craniopharyngioma |
151 |
0.11 |
158 |
0.12 |
|
|
|
|
|
|
Local Extensions from Regional Tumors
|
41 |
0.03 |
38 |
0.03 |
|
Chordoma/chondrosarcoma |
41 |
0.03 |
38 |
0.03 |
|
|
|
|
|
|
|
Unclassified Tumors |
844 |
0.74 |
1,033 |
0.66 |
|
Hemangioma |
67 |
0.05 |
73 |
0.05 |
|
Neoplasm,
unspecified |
765 |
0.68 |
948 |
0.60 |
|
All
other |
12 |
0.01 |
12 |
0.01 |
|
|
|
|
|
|
Total
|
17,585 |
14.22 |
20,199 |
13.86 |
aRates are per 100,000 person-years.
bIncludes data from 12 of the 16 registries listed in Table 5;
New Mexico, North Dakota, Rhode Island, and Texas are excluded.
- Counts are not presented when fewer than 6 cases were
reported for the specific histology category and rates are not presented when
fewer than 10 cases were reported for the specific histology category. The suppressed cases are included in the
counts and rates for Totals.
Abbreviations:
CBTRUS, Central Brain Tumor Registry of the United States; NOS, not
otherwise specified.
Disclaimer
The Central Brain Tumor Registry of the United States (CBTRUS) is a not-for-profit corporation which gathers and disseminates epidemiologic data on primary brain tumors in order to facilitate research and establish awareness of the disease. CBTRUS makes no representations or warranties, and gives no other assurances or guarantees, express or implied, with respect to the accuracy or completeness of the data presented. The information provided in this website is not intended to assist in the evaluation, diagnosis or treatment of individual diseases. Persons with questions regarding individual diseases should contact their own physician to obtain medical assistance.